The Finnish Medicines Agency (FIMEA) has extended Ark Therapeutics' GMP certification to include its newest and largest production facility in Kuopio, Finland. The 650m2 facility has been designed for larger scale production from suspension cell cultures utilising state-of-the-art single use systems and includes an automated fill and finish line capable.
Ark Therapeutics
Wednesday 25 April 2012
Ark plant receives approval
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment